Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Alexander Semaan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5424-3217; OpenAlex author ID A5041850254. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. Federated CT foundation models for multi-center detection of lymph node metastasis in pancreatic cancer. Co-author DOI 10.1038/s41598-026-47631-2↗
  2. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Co-author DOI 10.1038/s41586-025-08927-x↗
  3. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution. Co-author DOI 10.1038/s41467-022-31376-3↗
  4. Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Co-author DOI 10.1038/s41416-021-01350-9↗
  5. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution Co-author DOI 10.1101/2021.04.13.439717↗
  6. Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples. Co-author DOI 10.1158/1078-0432.ccr-20-2667↗
  7. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Co-author DOI 10.1158/1078-0432.ccr-20-3925↗
  8. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2018.09.022↗
  9. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progre… First author DOI 10.1158/1078-0432.ccr-18-1955↗
  10. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options. Co-author DOI 10.1038/nrgastro.2017.182↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 8 shared papers, 2018–2025 · strength 0.95
  2. Vincent Bernard · 8 shared papers, 2019–2025 · strength 0.90
  3. Paola A. Guerrero · 7 shared papers, 2019–2025 · strength 0.77
  4. Jaewon James Lee · 5 shared papers, 2021–2022 · strength 0.59
  5. Matthew H. G. Katz · 5 shared papers, 2019–2022 · strength 0.51
  6. Maria E. Monberg · 4 shared papers, 2021–2022 · strength 0.48
  7. Parinishtha Bhalla · 1 shared paper, 2026 · strength 0.29
  8. Shadi Albarqouni · 1 shared paper, 2026 · strength 0.29
  9. Matthäus Felsenstein · 1 shared paper, 2026 · strength 0.29
  10. Uli Fehrenbach · 1 shared paper, 2026 · strength 0.29
  11. Ken Chen · 2 shared papers, 2021–2022 · strength 0.26
  12. Cullen M. Taniguchi · 3 shared papers, 2019–2021 · strength 0.26
  13. Nabiollah Kamyabi · 3 shared papers, 2019–2021 · strength 0.25
  14. Hector A. Alvarez · 3 shared papers, 2019–2021 · strength 0.25
  15. Manoop S. Bhutani · 2 shared papers, 2021 · strength 0.22
  16. Brian R. Weston · 2 shared papers, 2021 · strength 0.22
  17. Paul A Scheet · 2 shared papers, 2019–2021 · strength 0.19
  18. Gauri Rajani Varadhachary · 2 shared papers, 2019–2021 · strength 0.18
  19. Thomas C. Caffrey · 1 shared paper, 2025 · strength 0.17
  20. Benson Chellakkan Selvanesan · 1 shared paper, 2025 · strength 0.17
  21. Jean L. Grem · 1 shared paper, 2025 · strength 0.17
  22. Fredrik I. Thege · 1 shared paper, 2025 · strength 0.17
  23. Jimin Min · 1 shared paper, 2025 · strength 0.17
  24. Bharti Garg · 1 shared paper, 2025 · strength 0.17
  25. Guangsheng Pei · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.